Canadian Medical Device Company Expands into Europe

Why Language Scientific?

Icentia is a Canadian medical device company focused on delivering innovative medical testing solutions for healthcare institutions. As the company prepared to expand beyond North America into the European market, Icentia required accurate, compliant translations of key product documentation. To support market entry in Europe, Icentia needed a partner capable of delivering certified translations, deep medical device subject matter expertise, and linguists native to the target countries. Language Scientific’s specialization in medical device translation made it a strong partner for this expansion initiative.

The Problem

Entering the European market required Icentia to translate patient and user-facing medical device documents to meet regulatory expectations and support product adoption. The challenges included:

  • Translating critical medical device documentation for European markets
  • Ensuring accuracy and clarity in Instructions for Use (IFUs) and patient materials
  • Meeting regulatory and quality requirements through certified translations
  • Supporting tight launch timelines for multiple countries simultaneously

Without timely and compliant translations, Icentia risked delaying its planned market.

Actions Taken

  • Translated Instructions for Use (IFUs), Patient Diaries, and Quick Installation Guides
  • Provided certified translations aligned with medical device compliance requirements
  • Applied deep medical device expertise to ensure regulatory and clinical accuracy
  • Delivered fast turnaround times and maintained competitive pricing

Related Posts

Plain language doesn’t stay plain in translation 

citybiz

Language Scientific Launches Dedicated 24/7 Clinical Helpline Practice for Global Trials

Pharmacy Language Access Is a Code-Red Patient Safety Problem, RxTran White Paper Warns

Medical Translation Services for Healthcare & Life Sciences

Medical translation changes when your translation partner thinks like a scientist 

Protecting Precision in FDA and EMA-regulated Translations 

rxtran logo

RxTran Awarded Second U.S. Patent for Technology That Lets Pharmacists Verify a Translation They Cannot Read